Yongjian Zhou

4PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 09, 2025
Long-term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial.

Jun Zhang, Yanqiao Zhang, Haibo Qiu

|Dec 09, 2025
Treatment research after failure of fourth-line standard therapy for advanced gastrointestinal stromal tumors: A review.

Xincheng Su, Shichai Hong, Zhenrong Yang

|Sep 30, 2025
The predictive value of the systemic inflammation-nutrition index for treatment response and prognosis in patients with locally advanced gastrointestinal stromal tumors receiving neoadjuvant imatinib therapy: a dual-center retrospective cohort study.

Zhiming Cai, Jinhu Chen, Zhenrong Yang

|Nov 30, 2023
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.

Michael C Heinrich, Xinhua Zhang, Robin L Jones

Pageof 1

Frequent Collaborators

2 joint publications

Xinhua Zhang

2 joint publications

Jian Li

1 joint publications

Michael C Heinrich

1 joint publications

Robin L Jones